A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

644

Participants

Timeline

Start Date

November 18, 2014

Primary Completion Date

September 16, 2016

Study Completion Date

September 16, 2016

Conditions
Depressive Disorder, Major
Interventions
DRUG

Levomilnacipran ER

Levomilnacipran ER taken orally at 40, 80 or 120 mg once daily.

DRUG

Placebo

Dose-matched placebo taken orally once daily.

Trial Locations (47)

10003

Forest Investigative Site 003, New York

10168

Forest Investigative Site 005, New York

10549

Forest Investigative Site 013, Mount Kisco

11235

Forest Investigative Site 031, Brooklyn

11516

Forest Investigative Site 036, Cedarhurst

14618

Forest Investigative Site 055, Rochester

19063

Forest Investigative Site 012, Media

22911

Forest Investigative Site 010, Charlottesville

24014

Forest Investigative Site 056, Roanoke

28211

Forest Investigative Site 058, Charlotte

30005

Forest Investigative Site 034, Alpharetta

30080

Forest Investigative Site 049, Smyrna

32250

Forest Investigative Site 008, Jacksonville Beach

32256

Forest Investigative Site 001, Jacksonville

32801

Forest Investigative Site 009, Orlando

33407

Forest Investigative Site 045, West Palm Beach

33912

Forest Investigative Site 018, Fort Myers

34201

Forest Investigative Site 023, Bradenton

34741

Forest Investigative Site 057, Kissimmee

35294

Forest Investigative Site 053, Birmingham

36303

Forest Investigative Site 050, Dothan

38119

Forest Investigative Site 030, Memphis

Forest Investigative Site 033, Memphis

45417

Forest Investigative Site 011, Dayton

53223

Forest Investigative Site 026, Brown Deer

60194

Forest Investigative Site 019, Schaumburg

74104

Forest Investigative Site 035, Tulsa

75243

Forest Investigative Site 054, Dallas

77090

Forest Investigative Site 059, Houston

84123

Forest Investigative Site 014, Murray

85032

Forest Investigative Site 039, Phoenix

90210

Forest Investigative Site 048, Beverly Hills

91316

Forest Investigative Site 021, Encino

91403

Forest Investigative Site 016, Sherman Oaks

Forest Investigative Site 037, Sherman Oaks

91710

Forest Investigative Site 047, Chino

91945

Forest Investigative Site 052, Lemon Grove

92056

Forest Investigative Site 042, Oceanside

92626

Forest Investigative Site 028, Costa Mesa

93065

Forest Investigative Site 043, Simi Valley

97210

Forest Investigative Site 046, Portland

97301

Forest Investigative Site 041, Salem

06475

Forest Investigative Site 040, Cromwell

06360

Forest Investigative Site 038, Norwich

01844

Forest Investigative Site 020, Methuen

02472

Forest Investigative Site 051, Watertown

08002

Forest Investigative Site 044, Cherry Hill

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY

NCT02288325 - A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder | Biotech Hunter | Biotech Hunter